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Salmonella paratyphi A is increasingly recognized as a common cause of enteric fever cases and there are
no licensed vaccines against this infection. Antibodies directed against the O-polysaccharide of the lipo-
polysaccharide of Salmonella are protective and conjugation of the O-polysaccharide to a carrier protein
represents a promising strategy for vaccine development. O-Acetylation of S. paratyphi A O-polysaccha-
ride is considered important for the immunogenicity of S. paratyphi A conjugate vaccines.
Here, as part of a programme to produce a bivalent conjugate vaccine against both S. typhi and
S. paratyphi A diseases, we have fully elucidated the O-polysaccharide structure of S. paratyphi A by
use of HPLC–SEC, HPAEC–PAD/CD, GLC, GLC–MS, 1D and 2D-NMR spectroscopy. In particular, chemical
and NMR studies identiﬁed the presence of O-acetyl groups on C-2 and C-3 of rhamnose in the lipopoly-
saccharide repeating unit, at variance with previous reports of O-acetylation at a single position. More-
over HR-MAS NMR analysis performed directly on bacterial pellets from several strains of S. paratyphi
A also showed O-acetylation on C-2 and C-3 of rhamnose, thus this pattern is common and not an artefact
from O-polysaccharide puriﬁcation. Conjugation of the O-polysaccharide to the carrier protein had little
impact on O-acetylation and therefore should not adversely affect the immunogenicity of the vaccine.
 2014 The Authors. Published by Elsevier Ltd. This is anopenaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Salmonella enterica serovars are responsible for invasive disease
in the developing world. Most cases of enteric fever are caused by
Salmonella enterica serovar typhi (S. typhi). The annual global bur-
den of disease due to typhoid fever was estimated at approxi-
mately 22 million illnesses in 2000 with a case-fatality rate of 1%
resulting in more than 200,000 deaths.1 The highest incidence
was reported in South Asia,1 and in pre-school and school-aged
children.2–4 An additional 5.4 million cases of enteric fever in
2000 were caused by Salmonella enterica serovar paratyphi A (S.
paratyphi A), with children mainly affected.1 A more recent revised
estimate of the global burden of typhoid and paratyphoid fever has
reported 26.9 million and 4.9 million adjusted cases of S. typhi and
S. paratyphi A, respectively, in 2010.5 S. paratyphi A is an increas-
ingly common cause of enteric fever in the Indian subcontinentand Southeast Asia, with data suggesting it may account for up
to 50% of enteric fever cases.6
There are licensed vaccines against S. typhi,7 but they do not
offer protection against enteric fever caused by S. paratyphi A.
The increasing frequency of S. paratyphi A as a cause of enteric
fever and the emergence of antibiotic resistance8 are of great con-
cern, particularly because there are no licensed vaccines against
S. paratyphi A infection. Furthermore, enteric fever caused by
S. paratyphi A and S. typhi is clinically indistinguishable. As a result,
in areas with high incidence of paratyphoid fever there is the risk
that even a highly effective S. typhi vaccine will be poorly efﬁca-
cious against enteric fever as a whole. To address enteric fever
more broadly, a combination vaccine that protects against both
S. typhi and S. paratyphi A would be a valuable public health tool.
The O-polysaccharide of the lipopolysaccharide (LPS) of
S. paratyphi A is a potentially protective antigen and therefore
the target for vaccine development. Phase 1 and 2 clinical studies
with an O-polysaccharide-TT vaccine9 were conducted 14 years
ago in Vietnamese adults and children and found to be safe and
immunogenic.10 The Chengdu Institutes of Biological Products in
China together with the Lanzhou Institute are currently conducting
N. Ravenscroft et al. / Carbohydrate Research 404 (2015) 108–116 109a Phase 2 trial of this vaccine.6,11 Other O-polysaccharide glycocon-
jugates using DT and CRM197 have been developed and tested in
preclinical studies by the International Vaccine Institute (IVI)6
and Novartis Vaccines Institute for Global Health (NVGH), respec-
tively.12 Both have been developed alongside Vi conjugate vaccines
in order to be used in bivalent combinations and protect against
both aetiologic agents of enteric fever.
Salmonella LPS consists of lipid A linked to the 3-deoxy-D-man-
no-octulosonic acid (Kdo) terminus of a conserved core region,
which is linked to the variable O-polysaccharide chain. In S. paraty-
phi A, the chain repeating unit consists of a trisaccharide backbone
composed of rhamnose (Rha), mannose (Man) and galactose (Gal),
with a terminal paratose (Par) at C-3 of Man (which confers sero-
group speciﬁcity: factor 2) and terminal glucose (Glc) at C-6 of
Gal (Fig. 1).
A common feature shared by various O-polysaccharides is the
presence of decorations such as O-acetyl groups. It has been
reported that not only the presence but also the position of O-
acetyl groups in the O-polysaccharide may inﬂuence the immune
response.13 The S. paratyphi A O-polysaccharide was reported to
require O-acetyl groups in order to elicit serum LPS antibody with
bactericidal activity in mice.9 In the case of S. paratyphi A, a single
site of O-acetylation has been reported, on C-3 of the Rha residue
as part of the repeating O-polysaccharide chain9,10,14,15 or on C-2
of the same monomer.16 However, from analysis of the 13C NMR
spectrum, Konadu et al. suggested the presence of two different
O-acetyl groups, the second one on the Par residue, akin to that
found on C-2 of abequose for S. typhimurium.17 The authors high-
lighted the need for further investigation given the important role
that O-acetyl groups seem to play in immunogenicity.9,10
In the O-polysaccharide puriﬁcation strategy adopted by NVGH,
the labile linkage between the Kdo of the core and the lipid A is
cleaved directly in the bacterial growth medium;18 the O-polysac-
charide, still linked to the core, is then easily puriﬁed from the cells
and can be used for the production of conjugate vaccines. For con-
jugation to CRM197, the S. paratyphi O-polysaccharide is linked to
the carrier protein through the terminal Kdo, with the aim to pre-
serve the O-polysaccharide antigen structure.12 Here the O-poly-
saccharide structure has been elucidated by use of HPLC–SEC,
HPAEC–PAD/CD, GLC, GLC–MS and 1D and 2D NMR studies. Heter-
ogeneity due to non-stoichiometric glucosylation and O-acetyla-
tion resulted in complex NMR spectra and simpler structures
were chemically derived to facilitate full assignment of the native
O-polysaccharide structure. In particular, the presence of O-acetyl
groups on both C-2 and C-3 of Rha was identiﬁed. The same pattern
of O-acetylation was found in the O-polysaccharide-CRM197 conju-
gate and on the surface carbohydrate of S. paratyphi A bacteria. This
conﬁrmed that the puriﬁcation and the conjugation processes do
not alter the structure of the O-polysaccharide antigen, including
retention of O-acetyl groups considered important for the immu-
nogenicity of the S. paratyphi A vaccine.Figure 1. Structure of the repeating unit of Salmonella paratyphi A O-polysaccharide
showing the positions of O-acetylation. The structural features that vary with the
strain of origin are shown in curved brackets.2. Results and discussion
2.1. Structural analysis of OPS
Puriﬁed O-polysaccharide (OPS) showed one main population
with an average molecular mass of 40–45 kDa.12,18 Sugar composi-
tion analysis of the OPS by GLC–MS analysis of the alditol acetate
derivatives showed the presence of Rha, Man, Gal, Glc and a
component eluting before Rha in the molar ratio
1.00:1.00:1.00:0.76:0.17, respectively. The early eluting compo-
nent was identiﬁed by GLC–MS as a 3,6-dideoxy-hexose, ascribed
to the expected Par, which was partially destroyed during acid
hydrolysis. In the absence of a commercially available monomer
standard, Par was quantiﬁed by 1H NMR analysis which yielded
the expected molar ratio of 1:1 with respect to Rha from the ratio
of the corresponding H-6 resonances. Incomplete glucosylation is
in agreement with HPAEC–PAD data (74%) previously reported.18
GLC analysis of the chiral glycosides of the OPS showed that the
hexoses were in the D absolute conﬁguration and Rha in the L abso-
lute conﬁguration. As before, the absence of a commercial standard
meant that analysis for Par could not be performed, and its D con-
ﬁguration was established by NMR glycosylation shifts. According
to GLC and GLC–MS of the partially-methylated alditol acetate
(PMAA) derivatives, OPS contains terminal non-reducing 3,6 dide-
oxyhexose, identiﬁed as Par by NMR (t-Par), 4-linked Rha (4-Rha),
terminal non-reducing glucose (t-Glc), 3-linked Gal (3-Gal), 2,3-
linked Man (2,3-Man) and 3,6-linked-Gal (3,6-Gal) in the molar
ratio 0.16:0.94:0.71:0.30:1.00:0.67. These data are consistent
with the OPS containing a mixture of 70% of the pentasaccharide
repeating unit (containing Glc-(1?6)-Gal) and 30% of the tetra-
saccharide repeating unit (without terminal glucose).18 In addition
to glucosylation, another source of the structural heterogeneity of
the OPS is due to variable O-acetylation. Our earlier studies on sev-
eral lots indicated a total O-acetyl content of 65–80% per repeating
unit determined by 1H NMR following in-tube de-O-acetylation
using sodium deuteroxide. In this study, the total O-acetylation
levels determined by HPAEC–CD were in agreement with values
found by 1H NMR and ranged from 65% to 75% per repeating unit
for OPS lots evaluated.
The 1H NMR spectrum of the OPS conﬁrmed the presence of the
two deoxy sugars with diagnostic signals for the H-3s of Par and H-
6 of Rha (split) and Par, but the anomeric region could not be read-
ily assigned due to overlap and the presence of multiple peaks. The
complexity of the OPS spectrum was attributed to the twinning of
some signals from incomplete glucosylation and the presence of
both the pentasaccharide (major) and tetrasaccharide (minor)
repeating units. This was further exacerbated by additional twin-
ning of signals due to partial O-acetylation (shown by signals at
2.20 and 2.18 ppm) and the presence of small peaks from the core
region and process residuals. Elucidation of these complex NMR
spectra was achieved after full assignment of the 1H and 13C
NMR spectra of simpler saccharides derived from OPS.2.2. Characterization of OPS Smith degradation products
Complete periodate oxidation of OPS, followed by reduction
with NaBH4 and mild acid hydrolysis (Smith degradation) yielded
an oligosaccharide (OPS-S1) as the major product. Full assignment
of OPS-S1 aided in the NMR interpretation of the polymer obtained
after partial Smith degradation to reduce the level of glucosylation
(OPS-S2), which in turn facilitated elucidation of the de-O-acety-
lated OPS (OPS-D) spectra and ﬁnally the spectra obtained for OPS.
The permethylated OPS-S1 gave the mass spectrum (Fig. S1A)
containing three ions at m/z 718.4, 723.4 and 739.4 corresponding
to the parent adducts [M+NH4]+, [M+Na]+, and [M+K]+, respectively.
110 N. Ravenscroft et al. / Carbohydrate Research 404 (2015) 108–116The MS2 spectrum gave information on the sequence (Fig. S1B) as a
trisaccharide Hex-[3,6-dideoxyHex]-Hex- attached to 1-deoxy-
erythritol (1dEry-ol), derived from oxidation between C-2 and
C-3 of the rhamnosyl ring. Detailed assignment of the ions is given
in Table S1. Identiﬁcation of OPS-S1 as a-D-Galp-(1?2)-[a-D-Parp-
(1?3)]-a-D-Manp-(1?2-1dEry-ol followed from detailed 1D and
2D NMR analysis (Supplementary data). A second Smith degrada-
tion using partial periodate oxidation of OPS was performed in
order to selectively remove the t-Glc residue and thereby increase
the proportion of the tetrasaccharide repeating unit in the OPS
preparation. Composition analysis by GLC of the alditol acetates
derivatives gave Rha/Man/Gal/Glc in the relative molar ratios
0.66:1.00:1.03:0.44, thus indicating a successful partial removal
of the t-Glc, but also some depletion of the Rha residue. As Rha is
a backbone residue, its decrease would be associated with some
in-chain cleavage and result in a lower molecular mass of the
sample. Therefore, the partial Smith degradation product was
separated on a Sephacryl S-300 size exclusion column and only
the fractions with the higher molecular mass were pooled together
to yield the polymeric OPS-S2 sample containing lower levels of
glucosylation.
2.3. Assignment of the NMR spectra of OPS-D
The 1H NMR spectra of OPS-S1, OPS-S2 and OPS-D are shown in
Figure S2 and the corresponding 13C NMR spectra in Figure S3. Elu-
cidation of the sugar spin systems for the pentasaccharide repeat-
ing unit (major component, RU5, residues in upper case) and
tetrasaccharide repeating unit (minor component, RU4, residues
in lower case) for OPS-D was achieved using the 1D and 2D NMR
experiments previously applied to OPS-S1 (Supplementary data).
The NMR study was hampered by the presence of heterogeneity
leading to signal overlap, and although the terminal Glc and Par
residues gave relatively sharp signals (and their spin systems wereFigure 2. Overlays of the anomeric regions of the HSQC spectra of S. paratyphi A O-
de-O-acetylated OPS-D (black), (B) de-O-acetylated OPS-D (red) and partially O-ac
pairs with upper case for the pentasaccharide repeating unit (P1 = H-1/C-1 of Par, etc
labelled with dashes (R1 = H-1/C-1 of Rha, R01 = H-1/C-1 of Rha3Ac, R001 = H-1/C-1 o
O-acetylation of Rha.readily assigned), those from the backbone residues, particularly
the 2,3-linked Man, gave broad signals and poor crosspeaks in
the 2D NMR spectra. These problems were overcome by extensive
use of hybrid experiments (HSQC-TOCSY and HSQC-NOESY) and
by repeating the NMR study using a high ﬁeld spectrometer
(600 MHz).
Comparison of the 1D 1H NMR spectra of OPS-S2 and OPS-D
(Fig. S2B and C) conﬁrmed that OPS-S2 contains a lower level of
Glc compared to OPS-D (25% vs 80%). The largest visible effect
of glucosylation was experienced by the anomeric signals of Man
[5.30 ppm (C-1 at 100.3 ppm) in RU4 shifts to 5.18 ppm (C-1 at
100.7 ppm) in RU5] and this is the main source of spectral com-
plexity in the anomeric region (see HSQC expansion, Fig. 2A). Once
this was realized, the ﬁve major spin systems were identiﬁed by
tracing correlations starting from H-1 (all), H-3 (Par) and H-6
(Par and Rha) resonances in COSY and TOCSY experiments and
the corresponding carbons through use of HSQC, HSQC-TOCSY
and HMBC experiments. The 1H and 13C NMR data are collected
in Table 1. Ambiguities in tracing out the Man (M) spin systems
were solved as for OPS-S1, by the HMBC crosspeaks from H-1
Man at 5.18 ppm to C-2 (small), C-3 and C-5 and the linkage shown
by the crosspeak from H-1 to C-4 Rha (82.1 ppm). The spin system
for the Man (m) from RU4 showed the same carbon correlations
from H-1 at 5.30 ppm, indicating that the effect of glucosylation
is mainly experienced by the anomeric position. The twinning
of the H-6/C-6 crosspeaks for Rha due to glucosylation
(1.32:17.7 ppm for r in RU4 and 1.34:17.9 ppm for R in RU5) pro-
vided a useful window for elucidation of these spin systems using
the HSQC-TOCSY and HMBC experiments. Here the twinning of sig-
nals was detectable for H-5, H-4 and H-1/C-1 (Table 1 and Fig. 2).
The a-L-Rhap-(1?3)-a-D-Galp linkage (not present in OPS-S1) was
shown by the HMBC crosspeak between H-1 Rha and C-3 of Gal at
77.9 ppm (partly overlapped with the H-1 Par/C-3 Man crosspeak
at 77.8 ppm) and conﬁrmed by the H-1/C-1 HSQC-NOESYpolysaccharide samples: (A) partial Smith degradation product OPS-S2 (red) and
etylated OPS (black). Crosspeaks are labelled according to the proton/carbon
.) and lower case for the tetrasaccharide repeating unit. The Rha O-acetylation is
f Rha2Ac). Dashes are also used to label twinning of the other residues due to
Table 1
NMR data of S. paratyphi A O-polysaccharide [de-OAc OPS-D (upper panel), part of the native OPS (lower panel)]
Residue H-1 H-2 H-3 H-4 H-5 H-6 O-Acetyl
C-1 C-2 C-3 C-4 C-5 C-6 Methyl CO
3)-a-D-Galp-(1?
(GA/ga)
5.24 3.95 3.96 4.16/4.05 4.23/4.07 3.79,3.69/3.71
101.7 68.4 77.9 69.5 69.8/72.0 66.8/61.7
a-D-Glcp-(1?
(GL)
4.95 3.56 3.73 3.42 3.66 3.87,3.76
99.6 72.0 73.8 70.1 72.9 61.3
4)-a-L-Rhap-(1?
(R/r)
5.06/5.04 4.08 3.97 3.60/3.55 3.96/3.93 1.34/1.32
102.7/102.6 71.1 69.8 82.1 68.7 17.9/17.7
2,3)-a-D-Manp-(1?
(M/m)
5.18/5.30 4.02/4.03 4.05 4.05 3.96 3.83
100.7/100.3 79.7 77.8 67.0 74.2 61.2
a-D-Parp-(1?
(P/p)
5.07/5.04 3.83 2.13,1.71 3.38 3.72 1.24/1.23
100.2 67.6 35.1 70.4 69.9 17.2
4)-a-L-Rhap-(1?
(R)
5.06 4.07 3.96 3.60 3.96 1.34
102.5 71.1 69.8 82.1 68.7 17.7
4)-a-L-Rhap3Ac-(1?
(R0)
5.09 4.21 5.19 3.88 4.06 1.36 2.20
102.3 68.9 73.4 78.6 68.9 18.1 21.6 174.1
4)-a-L-Rhap2Ac-(1?
(R00)
5.10 5.20 4.19 3.63 4.02 1.37 2.18
99.6 73.5 68.2 81.5 68.8 18.0 21.1 173.9
2,3)-a-D-Manp-(1?
(M/M0 and M00)
5.18 4.02/4.03 4.05 4.05 3.96 3.83
100.7/100.3 79.7/79.4 77.8 67.0 74.2 61.2
OPS-D: the residues of the major pentasaccharide repeating unit are indicated by upper case (e.g. Gal = GA) and the minor tetrasaccharide repeating unit by lower case (e.g.
Gal = GA). Deshielded ring carbons (linkage positions) are underlined. The spectra were recorded at 303 K (600 MHz) and referenced to residual sodium acetate (present after
de-O-acetylation). OPS: only the residues of the pentasaccharide repeating unit affected by O-acetylation are presented; minor peaks due to the presence of the tetrasac-
charide repeating unit are not listed. The Rha, Rha3Ac and Rha2Ac spin systems are represented by R, R0 and R00 , respectively, and the corresponding spin systems of Man byM,
M0 and M00 . The NMR spectra were recorded at 303 K (600 MHz) and referenced to DMSO.
Figure 3. GLC chromatograms of the PMAA derivatives obtained from permethy-
lation of S. paratyphi A O-polysaccharide: (A) without, (B) with retention of O-acetyl
groups. Peak assignments are reported: t-Par = terminal non-reducing Par; 4-Rha-3-
Ac = 4-linked rhamnose acetylated on C-3; 4-Rha-2-Ac = 4-linked rhamnose acet-
ylated on C-2. The numbers indicate the position of hydroxyl functions engaged in
linkages.
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identiﬁed from examination of the 1D and 2D NMR spectra
obtained for OPS-S2 (mainly Gal ga in RU4) and OPS-D (mainly
Gal GA in RU5). The HMBC experiments from H-1 of Gal gave
crosspeaks to C-3 and C-5 of the residues and the crosspeak from
H-1 to 79.7 ppm (C-2 Man) conﬁrmed the a-D-Galp-(1?2)-D-Manp
linkage. The location of glucosylation on C-6 of Gal in RU5 was
demonstrated by the deshielding of C-6 of Gal in RU4 (from 61.7
to 66.8 ppm) with concomitant shielding of C-5 (from 72.0 to
69.8 ppm) and deshielding of the attached H-5 (from 4.07 to
4.23 ppm). This was conﬁrmed by HMBC crosspeaks between H-
1 of Glc (4.95 ppm) and C-6 of Gal. Lastly, proof of the a-D-Parp-
(1?3)-a-D-Manp linkage was shown by the H-1 Par/C-3 Man
crosspeak in the HMBC spectrum thereby conﬁrming the structure
of the pentasaccharide repeating unit:?2)-[a-D-Parp-(1?3)]-a-D-
Manp-(1?4)-a-L-Rhap-(1?3-[a-D-Glcp-(1?6)]-a-D-Galp-(1?
(Fig. 1). Modelling studies were performed to account for the major
chemical shift inﬂuence observed from glucosylation (H-1 Man and
H-4 to H-6 Rha); the favored orientations of phi/psi dihedral angles
for each of the glycosidic linkages in the pentasaccharide repeating
unit bring Glc in close proximity to the Man and Rha backbone res-
idues.19 Additional crosspeaks were observed corresponding to
small peaks in the 1D spectra derived from the core oligosaccha-
ride as well as the non-reducing terminal of the OPS a-D-Parp-
(1?3)-a-D-Manp-(1? [with H-1, C-1 Par at 4.04 and 102.2 ppm
and H-1, C-1 Man at 4.98 and 102.0 ppm, respectively]. Character-
ization of terminal residues of the Salmonella typhimurium O-poly-
saccharide chain has been reported;20 it was also detected in our
NMR studies performed on Salmonella typhimurium.21
2.4. Chemical and NMR characterization of OPS O-acetylation
The pattern of O-acetylation of OPSwas investigated chemically
and by use of NMR spectroscopy. OPS was permethylated follow-
ing the method of Prehm,22 which leaves the O-acetyl groups in
their native positions, thus allowing the determination of their
location. GLC chromatograms of the PMAA derivatives for the O-
polysaccharide obtained without (A) and with (B) retention of
the O-acetyl groups (Fig. 3) showed the presence of two new peakscorresponding to 3,4-linked Rha and 2,4-linked Rha and a decrease
in the peak intensity of 4-linked Rha. Although the peaks corre-
sponding to 4-Rha and t-Glc overlap on the SP2330 column, inte-
gration of the signals corresponding to the new Rha derivatives
indicated that the 34% of the 4-linked Rha was acetylated on C-3
and 25% on C-2 (Table 2). Subsequent GLC–MS of the samples on
Table 2
Determination of the glycosidic linkages in S. paratyphi A O-polysaccharide by GLC-
MS of PMAA derivatives
Linkage RRTa Ib IIc
t-Pard 0.435 0.26 0.26
4-Rha 0.726 0.93 0.40
t-Glc 0.731 0.66 0.72
3,4-Rha 0.824 — 0.34
2,4-Rha 0.877 — 0.25
3-Gal 0.906 0.24 0.23
2,3-Man 1.000 1.00 1.00
3,6-Gal 1.142 0.61 0.66
a Relative retention time.
b I = OPS methylated without retention of O-acetyl groups.
c II = OPS methylated with retention of O-acetyl groups.
d t-Par = the amount of this derivative is underestimated because it is acid labile.
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tion (of the MS signal) gave similar results with 31% of the 4-linked
Rha acetylated on C-3 and 21% on C-2, with the relative intensity of
4-Rha decreasing from 0.74 to 0.34.
The 1H NMR spectrum of OPS contained two signals at 2.20 and
2.18 ppm (Fig. 4A), not present in OPS-D (Fig. S2C); these were
attributed to the two O-acetyl groups detected chemically. An
overlay of the 13C NMR spectra of OPS and OPS-D (Fig. 5) showed
a decrease in intensity of the Rha (R) signals and the appearance of
several new signals attributed to Rha3Ac (R0) and Rha2Ac (R00).
These spin systems were assigned using a full array of 2D
experiments; a combination of the HSQC-NOESY (Fig. 6A) and
HSQC-TOCSY (Fig. 6B) experiments were particularly useful in
establishing connectivities from the O-acetyl signals (at 2.20 and
2.18 ppm) and the H-6/C-6 resonances, respectively, to the carbons
of the Rha3Ac (R0) and Rha2Ac (R00) residues. Initial studies
indicated a single position of O-acetylation manifest by a singleFigure 4. 1H NMR spectra of S. paratyphi A samples: (A) partially O-acetylated O-pol
assignments are labelled, upper case for the pentasaccharide repeating unit (P1 = H-1 of P
of Rha3Ac, R001 = H-1 of Rha2Ac). An arrow indicates O-acetyl signals.HSQC crosspeak as recently reported.15 However, repeating the
NMR study at higher ﬁeld (600 MHz) revealed the presence of
overlapping crosspeaks due to Rha3Ac (major, R0 at 5.19/
73.4 ppm) and Rha2Ac (minor, R00 at 5.20/73.5 ppm). The HMBC
experiment permitted identiﬁcation of the acetyl carbons (at
174.1 and 173.9 ppm) from the signals at 2.20 and 2.18 ppm, and
the carbonyls gave small crosspeaks to the corresponding ring pro-
tons in the anomeric region. The NMR data are collected in Table 1.
For Rha3Ac, the presence of the O-acetyl group on C-3 resulted in
deshielding of H-3 (+1.23 ppm) and C-3 (+3.6 ppm) and shielding
of the adjacent carbons C-2 (2.2 ppm) and C-4 (3.5 ppm),
whereas for Rha2Ac, H-2 (+1.13 ppm) and C-2 (+2.4 ppm) were
deshielded and the adjacent carbons C-1 (2.9 ppm) and C-3
(1.6 ppm) shielded. The effects of O-acetylation on Rha are
comparable to those reported for ?4)-a-Rha2/3Ac in Salmonella
typhimurium21 and a strain of Aeromonas sobria.23 The major effect
of O-acetylation on the rest of the sugars in the repeating unit was
a slight shielding for positions 1 and 2 of the a-Man substituent at
C-4 of the O-acetylated Rha and the anomeric positions of Gal and
Par (see HSQC expansion, Fig. 2B).
Estimation of the relative intensities of the O-acetyl groups at
2.20 and 2.18 ppm compared to H-6 of Rha indicated a degree of
O-acetylation of 30% and 20% at positions C-3 and C-2, respectively.
2.5. Little impact of conjugation on OPS O-acetylation pattern
Similar relative intensities of the O-acetyl signals were obtained
for the derived conjugate OPS-CRM197 (previously12 designated as
O:2-CRM197), proving that the conjugation process had little
impact on the pattern of O-acetylation although there was a small
decrease in total O-acetylation (Fig. 4B). A third smaller peak at
2.16 ppm (with CH3 at 21.0 ppm and carbonyl at 173.8 ppm) was
assumed to be a third position of O-acetylation, however,ysaccharide OPS, (B) the puriﬁed O-polysaccharide conjugate OPS-CRM197. Some
ar, etc.) and the Rha O-acetylation is labelled with dashes (R1 = H-1 of Rha, R01 = H-1
Figure 5. 13C NMR spectra of S. paratyphi A O-polysaccharide samples: (A) partially O-acetylated O-polysaccharide OPS, (B) de-O-acetylated OPS-D. The inserts show the
methyl and methylene region of the spectra. Some assignments are labelled, upper case for the pentasaccharide repeating unit (P1 = C-1 of Par, etc.) and the Rha O-acetylation
is labelled with dashes (R1 = C-1 of Rha, R01 = C-1 of Rha3Ac, R001 = C-1 of Rha2Ac). Dashes are also used to label twinning of the other residues due to O-acetylation of Rha. An
arrow indicates the O-acetylated carbons.
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established and the peak is absent from the NMR spectrum of
OPS-CRM197. This peak could explain the higher total O-acetylation
levels determined by NMR after in-tube de-O-acetylation or
HPAEC–PAD compared to NMR analysis of the intact O-acetylated
O-polysaccharide.
2.6. HR-MAS NMR analysis on bacterial pellets conﬁrming O-
acetylation pattern found on puriﬁed OPS
The O-acetylation pattern of O-polysaccharide expressed on
surface of bacteria was also investigated in light of literature
reports regarding a single position of O-acetylation and the possi-
bility that the O-acetylation observed on C-2 and C-3 of Rha of OPS
may arise from migration during O-polysaccharide preparation.
HR-MAS NMR analysis, used to track the pattern of O-acetylation
on live Salmonella typhimurium bacteria,24 was performed on bac-
terial pellets from three clinical isolates and a genetically modiﬁed
S. paratyphi A strain. The 1H NMR spectra obtained (Fig. 7A–D)
showed that all cells contain two peaks (1:1 ratio) in the O-acetyl
region assigned to O-acetylation on C-2 and C-3 of Rha. This proves
that O-acetylation on both positions is common to different S.
paratyphi A strains and it is not an artefact introduced during O-
polysaccharide isolation and puriﬁcation, corroborated by a com-
parison of the O-acetylation on the surface of bacteria (Fig. 7D)
and on the O-polysaccharide puriﬁed from the homologous strain
(Fig. 7E). Puriﬁed OPS has O-acetylation of 30% and 18% at posi-
tions C-3 and C-2 of Rha (compared to H-6 of Rha), suggesting that
although some migration may occur during O-polysaccharide
puriﬁcation, it results in a consistent 3:2 ratio at positions C-3and C-2 of Rha. The facile migration between positions C-2
and C-3 has been reported for methyl glycosides of O-acetylated
a-L-Rhap.25
3. Conclusions
As part of a project to develop a bivalent conjugate vaccine
against both S. typhi and S. paratyphi A infections, we have fully
characterized the O-polysaccharide from S. paratyphi A. Sugar anal-
ysis by GLC-MS conﬁrmed the composition of the tetrasaccharide
repeating unit as Man, Gal, Rha and Par together with non-stoichi-
ometric amounts (75%) of glucosylation; this is in agreement
with HPAEC–PAD data previously reported.18 The structure of the
repeating unit was conﬁrmed by linkage analysis which showed
that the terminal glucose present was linked 1?6 to Gal. Incom-
plete glucosylation and O-acetylation resulted in complex NMR
spectra and simpler structures obtained by chemical modiﬁcation
of the native O-polysaccharide permitted assignment of the repeat-
ing unit backbone and determination of the location and extent of
O-acetylation. The presence of O-acetyl groups on C-2 and C-3 of
Rha was conﬁrmed by linkage analysis and GLC-MS; this is in con-
trast to previous literature reports of a single position of O-acety-
lation.9,10,14–16 The NMR assignments permitted evaluation of the
O-acetylation pattern of the O-polysaccharide from a second S.
paratyphi A strain as well as the surface of several different strains
by use of HR-MAS NMR. All S. paratyphi A screened were O-acety-
lated on C-2 and C-3 of Rha suggesting that this is a common phe-
notype. Additionally, conjugation of the O-polysaccharide to a
carrier protein had no impact on the position of the O-acetyl
groups. Considering the importance of this decoration for the
Figure 6. Expansions of the 1H–13C hybrid 2D NMR experiments performed on partially O-acetylated O-polysaccharide OPS (A) HSQC-NOESY spectrum (mixing time of
250 ms), (B) HSQC-TOCSY spectrum (mixing time of 120 ms). Key H/C correlations are labelled, upper case for the pentasaccharide repeating unit and the Rha O-acetylation is
labelled with dashes (H-R1 = H-1 of Rha, H-R01 = H-1 of Rha3Ac, H-R001 = H-1 of Rha2Ac). Crosspeaks are labelled H/C (H-P6/C-P2 = H-6 Par/C-2 Par, etc.) The 1H acetyl signals
of Rha3Ac and Rha2Ac are labelled as H-R0Ac and H-R00Ac, respectively. An arrow indicates the O-acetylated carbons.
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the structure of critical epitopes of the O-polysaccharide from the
bacteria through to conjugate formation increases the likelihood of
success of this much needed vaccine.
4. Experimental
4.1. Strains
S. paratyphi A used in this study were either clinical isolates,
obtained from University of Oxford and Patan Hospital, Kathmandu
Nepal (NVGH307, NVGH309, NVGH310) or genetically modiﬁed
strains, prepared in house or supplied by the Center for Vaccine
Development, University of Maryland (NVGH2041 and CVD 1901).
4.2. Samples
OPS was puriﬁed as previously described.18 All preparations
were characterized by protein content <1% (mg/mg OPS; by micro
BCA), nucleic acid content <0.5% (mg/mg OPS; by absorption at
260 nm) and endotoxin level <0.1 UI/lg (by LAL).
De-O-acetylation of OPS was performed in the NMR tube, how-
ever the higher pH and ionic strength resulted in minor chemical
shift differences with the parent OPS sample that hampered direct
comparison of the spectra. Therefore the OPS-D sample was
obtained by de-O-acetylation of the O-polysaccharide sample
(200 mMNaOH at 37 C for 2 h) followed by recovery of the sample
by freeze-drying after dialysis against water.
The O-polysaccharide conjugate (OPS-CRM197) was prepared as
previously described.12 Brieﬂy the sugar chain was linked to adipicacid dihydrazide (ADH) by reductive amination through the ketone
group of its terminal Kdo sugar. An additional linker, SIDEA, was
then attached to ADH before conjugation to the carrier
protein. The conjugate prepared for this structural analysis was
characterized by a saccharide to CRM197 w/w ratio of 2.7, with
no free CRM197 detectable (by HPLC–SEC)12 and less than 10% free
saccharide (following precipitation of the conjugate with
deoxycholate).26
4.3. Smith degradation of OPS to yield OPS-S1 and OPS-S2
OPSwas subjected to complete oxidationwithNaIO4,27,28 by dis-
solving 180 mg of the sample in 50 mL of 30 mMNaIO4 and incubat-
ing at 10 C for 7 days in the dark. The reaction was stopped by the
addition of glycerol and the products were reduced with NaBH4.
Addition of 50% CH3COOH after 16 h destroyed the excess of reduc-
ing reagent, the sample was dialysed and the solution volume sub-
sequently reduced to 10 mL. TFA was added in order to have a
ﬁnal concentration of 0.1 M and the hydrolysis was conducted at
room temperature for 7 days. The solution was taken to dryness
under reduced pressure, dissolved in water, its pH adjusted to neu-
trality, and the product was recovered by lyophilization. It was then
separated on a Bio Gel P2 column (1.6 cm i.d.  90 cm) equilibrated
in 50 mM NaNO3 which was also used as eluent. The ﬂow rate was
6 mL/h and fractions were collected at 15 min intervals. Elution
was monitored using a refractive index detector (WGE Dr. Bures,
LabService Analitica) connected to a paper recorder and interfaced
with a computer via picolog software. One major oligosaccharide,
namedOPS-S1, was obtained from the chromatographic separation
and analysed by NMR and ESI-MS.
Figure 7. Expansions of the 1H HR-MAS-NMR spectra of S. paratyphi A samples: (A) clinical isolate NVGH307, (B) clinical isolate NVGH309, (C) clinical isolate NVGH310, (D)
genetically modiﬁed strain NVGH2041, and (E) the 1H NMR spectrum the O-polysaccharide puriﬁed from strain NVGH2041. An arrow indicates the O-acetyl signals and some
assignments are labelled with Rha O-acetylation indicated with dashes (R6 = H-6 of Rha, R06 = H-6 of Rha3Ac, R006 = H-6 of Rha2Ac).
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selectively remove the t-Glc residue: 21 mg of sample were dis-
solved in 7 mL of 16 mM NaIO4 and stirred for 75 min at 10 C in
the dark. The oxidation was then stopped by addition of glycerol
and the products were treated as reported above. Reduction of the
aldehyde groups with NaBH4 resulted in de-O-acetylation. After a
mild hydrolysis for 7 days with 0.05 M TFA, the sample was taken
to dryness under reduced pressure in order to remove most of the
acid, then taken to neutral pH and recovered by lyophilization. The
sample was subjected to composition analysis and then separated
on a Sephacryl S-300 column (1.6 cm i.d.  92 cm), equilibrated in
50 mM NaNO3 and using the same solution as eluent. The ﬂow rate
was 6 mL/h and fractionswere collected at 15 min intervals. Elution
was monitored as reported above for the sample OPS-S1. The frac-
tionswith the highestmolecularmasswere pooled together, named
OPS-S2 and investigated by NMR spectroscopy.
4.4. Chemical analysis
Analytical GLC was performed on a Perkin Elmer Autosystem XL
gas chromatograph equipped with a ﬂame ionization detector and
an SP2330 capillary column (Supelco, 30 m), using He as carrier
gas. The following temperature programmes were used: for alditol
acetates, 200–245 C at 4 C/min; for partially methylated alditol
acetates, 150–250 C at 4 C/min. Separation of the trimethylsily-
lated (+)-2-butyl glycosides was obtained on a HP-1 column (Hew-
lett–Packard, 50 m), using the following temperature programme:
50 C 1 min, 50–130 C at 45 C/min, hold 1 min, 130–240 C at
1 C/min, hold 20 min. GLC–MS analyses were carried out on an
Agilent Technologies 7890A gas chromatograph coupled to an Agi-
lent Technologies 5975C VL MSD. Hydrolysis of the samples was
performed with 2 M TFA for 1 h at 125 C. Alditol acetates were
prepared as already described.29 Permethylation of polysaccharidesand oligosaccharides was achieved following the protocols by
Harris30 and Dell,31 respectively. The method of Prehm was used
to methylate OPS without removal of O-acetyl groups.22
Determination of the absolute conﬁguration of the sugar resi-
dues was performed as described.32
Quantiﬁcation of total O-acetylation was performed by use of
high-performance anion-exchange chromatography with conduc-
tivity detection (HPAEC–CD). OPS samples (total volume of
225 lL) were added with 25 lL of 200 lg/mL sodium propionate
in 100 mM NaOH. The samples were heated at 37 C for 4 h. Sam-
ples were then ﬁltered with 0.45 lm Acrodisc (PALL) ﬁlters before
chromatographic analysis. Calibration curve was built using
sodium acetate as standard in the range of 0.5–10 lg/mL. The stan-
dards were treated and analysed as described for the samples.
HPAEC–CD was performed with a Dionex ICS3000 equipped with
a Dionex IonPac AS11 (4  250 mm) coupled with IonPac AG11
Guard Column (4  50 mm) and quantiﬁed by a conductivity
detector with ASRS suppressor under 2 mM NaOH elution.
4.5. ESI MS analysis
ESI mass spectra were recorded on a Bruker Esquire 4000 ion
trap mass spectrometer connected to a syringe pump for the injec-
tion of the samples. The instrument was calibrated using a tune
mixture provided by Bruker. Permethylated samples were dis-
solved in chloroform/methanol/0.75 M NH4OAc 1:1:0.03 (v/v/v)
at an appropriate concentration and injected at 180 lL/h. Detec-
tion was always performed in the positive ion mode.
4.6. NMR spectroscopy
Samples of OPS [90 mg (400 MHz study) and 20 mg (600 MHz
study)], OPS-D (70 mg), OPS-S1 (10 mg), OPS-S2 (6 mg) and
116 N. Ravenscroft et al. / Carbohydrate Research 404 (2015) 108–116OPS-CRM197 (1.9 mg saccharide) were prepared for NMR analysis
by repeatedly dissolving and drying the sample in D2O. NMR
spectra were acquired on samples dissolved in D2O (0.6 mL,
Aldrich) and transferred to 5 mm NMR tubes (Wilmad). Spectra
were also recorded on an OPS sample after the addition of
sodium deuteroxide to a ﬁnal concentration of 200 mM in order
to achieve de-O-acetylation in the NMR tube. 1D (1H and 13C)
and 2D COSY, TOCSY, NOESY, HSQC, HMBC and hybrid HSQC-
TOCSY and HSQC-NOESY NMR spectra were obtained using a Bru-
ker Avance III 400 MHz spectrometer. Many of the experiments
were repeated using a Bruker Avance III 600 MHz NMR spectrom-
eter equipped with a BBO Prodigy cryoprobe. The probe temper-
ature was set at 303 K and the spectra were acquired and
processed using standard Bruker software (Topspin 3.2). 2D TOC-
SY experiments were performed using mixing times of 120 and
180 ms and the 1D variants using mixing times of 200 or
250 ms. The HSQC experiment was optimized for J = 145 Hz (for
directly attached 1H–13C correlations), and the HMBC experiment
optimized for a coupling constant of 8, 6 or 5 Hz (for long-range
1H–13C correlations). HSQC-TOCSY and HSQC-NOESY NMR spectra
were recorded using mixing times of 120 and 250 ms, respec-
tively. Spectra were referenced to residual acetate (1H signal at
1.903 ppm and 13C signal at 23.97 ppm, DMSO (1H signal at
2.71 ppm and 13C signal at 39.39 ppm33 or acetone (1H signal
at 2.225 ppm and 13C signal at 31.45 ppm).
Proton high-resolution magic angle spinning (HR-MAS) NMR
spectra were recorded on bacterial pellets as previously described
for S. typhimurium.18 The spectra were recorded on a Bruker Avance
III 400-MHz spectrometer using a Bruker 4-mm HR-MAS probe.
Samples were spun at 4.5 kHz at 25 C and the proton spectra
acquired with a diffusion ﬁlter pulse sequence to remove sharp
lines arising from low-molecular-mass species in solutin.Acknowledgements
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